Wolverine Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,000
Closed -$365K 2510
2022
Q2
$365K Sell
11,000
-100
-0.9% -$4.25K ﹤0.01% 1064
2022
Q1
$800K Sell
11,100
-11,000
-50% -$792K 0.01% 835
2021
Q4
$2.03M Hold
22,100
0.02% 550
2021
Q3
$2.8M Hold
22,100
0.02% 404
2021
Q2
$3.67M Hold
22,100
0.03% 321
2021
Q1
$4.02M Buy
22,100
+5,500
+33% +$1.28M 0.03% 276
2020
Q4
$3.32M Buy
16,600
+12,100
+269% +$2.46M 0.02% 322
2020
Q3
$986K Hold
4,500
0.01% 571
2020
Q2
$858K Hold
4,500
0.01% 582
2020
Q1
$697K Sell
4,500
-15,100
-77% -$1.76M 0.01% 598
2019
Q4
$1.64M Buy
19,600
+1,400
+8% +$107K 0.02% 488
2019
Q3
$1.23M Sell
18,200
-300
-2% -$19.7K 0.02% 543
2019
Q2
$1.23M Buy
18,500
+1,900
+11% +$111K 0.02% 575
2019
Q1
$922K Buy
+16,600
New +$1.01M 0.01% 689
2018
Q3
Sell
-5,700
Closed -$330K 1635
2018
Q2
$330K Sell
5,700
-12,400
-69% -$606K ﹤0.01% 1021
2018
Q1
$729K Sell
18,100
-91,100
-83% -$3.44M 0.01% 876
2017
Q4
$3.81M Sell
109,200
-6,300
-5% -$209K 0.04% 340
2017
Q3
$3.83M Buy
+115,500
New +$3.79M 0.04% 308

Other funds holding TDOC

Wolverine Asset Management's TDOC Position: Q1 2023 in Review

Wolverine Asset Management sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 2 shares — an estimated $47 sold.

Wolverine Asset Management first reported a position in TDOC in Q1 2018 and held it in 10 quarters. The position peaked at $2.24M in Q2 2019. 429 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.

  • Wolverine Asset Management reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
  • Wolverine Asset Management sold 2 Teladoc Health shares in Q1 2023, an estimated $47.
  • Wolverine Asset Management first reported a position in Teladoc Health in Q1 2018 and held it in 10 quarters.
  • Wolverine Asset Management's Teladoc Health position peaked at $2.24M in Q2 2019.
  • 429 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.

Based on Wolverine Asset Management's 13F filing for Q1 2023, filed 8 May 2023.